The Binge-Eating Disorder Treatment Market is being driven by Increasing prevalence of binge-eating disorder
The Binge-Eating Disorder Treatment Market is expected to grow at a CAGR of 7% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 627.4 million. The binge-eating disorder (BED) treatment market is experiencing significant growth due to the rising prevalence of this condition. Pharmaceutical companies are investing heavily in research and development of novel therapies to address BED. For instance, the TANDEM trial, initiated by researchers at the IoPPN, Kings College London in 2024, tested a groundbreaking home-administered treatment combining transcranial direct current stimulation (tDCS) with attention bias modification training (ABMT). This innovative approach aims to modify unhelpful food-related attention patterns and enhance self-regulation in individuals with BED. The trial, which included 82 participants, demonstrated promising results, reducing binge-eating episodes, improving mood, and supporting weight loss. This new treatment approach represents a significant step forward in the development of effective BED therapies.
Get more information on Binge-Eating Disorder Treatment Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
218 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7% |
Market growth 2025-2029 |
USD 627.4 million |
Market structure |
fragmentation |
YoY growth 2024-2025(%) |
6.5 |
Key countries |
US, Canada, China, Germany, UK, France, Italy, Japan, Spain, and India |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Binge-Eating Disorder (BED) treatment market encompasses various approaches, including mindfulness-based therapies, motivational interviewing, nutritional education, pharmacological interventions, individual therapy, eating disorder assessments, and diagnostic criteria. Treatment plans may incorporate understanding eating disorder severity and subtypes, such as bulimia nervosa, anorexia nervosa, rumination disorder, night eating syndrome, body dysmorphic disorder, and others. New treatments like weight loss surgery, lifestyle modifications, behavioral interventions, and multidisciplinary team approaches are also being explored. Recovery from BED involves setting treatment goals, seeking support networks, peer support, and advocacy groups throughout the journey.
The Binge-Eating Disorder (BED) Treatment Market is a significant segment within the global pharmaceuticals industry, encompassing organizations involved in the research and development (R&D) or production of various drug types, including generic and non-generic medications, as well as veterinary drugs. According to Technavio, the healthcare market size is determined by the consolidated revenue generated by manufacturers and providers of medical equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The expansion of the global pharmaceuticals market will be fueled by several factors, including the increasing elderly population. By 2050, approximately one-quarter of the US population and by 2030 in Europe are projected to be over 60 years old. Evidence-based therapeutic approaches for BED include cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), interpersonal therapy, and nutritional counseling, in addition to medication management. These interventions are crucial for addressing the complex psychological and physiological aspects of BED.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted